tetrahydrocannabinol acetate

Tetrahydrocannabinol acetate (THC-O-acetate) is a synthetic cannabinoid and a prodrug of delta-9-tetrahydrocannabinol (THC). It is synthesized through the acetylation of THC using acetic anhydride, a chemical process that increases the compound's lipophilicity and potentially its physiological potency compared to naturally occurring THC. Once consumed, the acetyl group is metabolically removed, allowing the active THC molecule to bind to and activate cannabinoid receptors in the central nervous system. Although it has appeared in the recreational market, often marketed as a hemp-derived product, there is no evidence of formal pharmaceutical development or clinical trials by biotechnology or pharmaceutical companies. Its legal status is a subject of significant debate; while some argue it is protected under hemp-related legislation, the U.S. Drug Enforcement Administration (DEA) has classified it as a Schedule I controlled substance because it does not occur naturally in the cannabis plant.

Other names

THC-O-acetateTHC-OATHCdelta-9-THC acetatedelta9-THC acetatedelta 9-THC acetate